Medical News

RSS

FDA grants Cepheid marketing clearance for Xpert SA Nasal Complete molecular test

Cepheid today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert® SA Nasal Complete, the first and only molecular test designed for the simultaneous detection and differentiation of both Staphylococcus aureus (SA) and Methicillin-resistant Staphylococcus aureus (MRSA) colonization in less than one hour. The test runs on Cepheid's GeneXpert® System, the world's leading molecular platform for accuracy, speed, and ease-of-use.

8 Jun 2010

Patient Home Monitoring to trade under ticker symbol "PHM" on TSX Venture Exchange

Patient Home Monitoring, a company focused on in-home cardiology healthcare services, today announced that it will begin trading under the ticker symbol "PHM" on the TSX Venture Exchange at the open of market today, Tuesday, June 8, 2010.

8 Jun 2010

New technique to prevent tumours developing in connection with stem cell transplantations

Researchers at Lund University have come up with a new technique to prevent tumours developing in connection with stem cell transplantations. The results have been published today in the respected scientific journal PNAS.

8 Jun 2010

Salix submits efficacy supplement for XIFAXAN NDA for Non-C IBS and IBS-related bloating

Salix Pharmaceuticals, Ltd. today announced that the Company has submitted an efficacy supplement to NDA 21-361 for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.

8 Jun 2010

$UC-MSCT improves symptoms, biochemical values in patients with severe refractory SLE: Study$

UC-MSCT improves symptoms, biochemical values in patients with severe refractory SLE: Study

A new study shows that umbilical cord mesenchymal stem cell transplant may improve symptoms and biochemical values in patients with severe refractory systemic lupus erythematosus.

8 Jun 2010

Columbia completes enrollment in PROCHIEVE 8% Phase III study to reduce preterm birth in short cervix women

Columbia Laboratories, Inc. today announced it completed enrollment in the PREGNANT (PROCHIEVE Extending GestatioN A New Therapy) Study last week. This randomized, double-blind, placebo controlled Phase III clinical study is evaluating the safety and efficacy of PROCHIEVE® 8% (progesterone gel) to reduce the risk of preterm birth in women with a cervical length between 1.0 and 2.0 centimeters as measured by transvaginal ultrasound at mid-pregnancy.

8 Jun 2010

USPTO grants ISCO patent to International Stem Cell's hpSC

International Stem Cell Corporation, www.intlstemcell.com, announced today that the United States Patent and Trademark Office has granted ISCO patent number 7,732,202, the first of several pending patents relating to its development of human parthenogenetic Stem Cells. Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching to potentially solve critical immune rejection problems, and does not involve the ethical issues that surround the use of fertilized human embryos.

8 Jun 2010

Value-based wellness programs for patients with metabolic syndrome

HealthInsight, provider of the leading health incentive platform, today announced a new addition to its value-based wellness programs for patients with metabolic syndrome. The program is designed to detect and manage the syndrome's symptoms before the condition becomes chronic, thereby allowing individuals to take preventive action and manage their overall health while reducing on-going treatment costs.

8 Jun 2010

Research project to transform primary care practices into patient-centered medical homes concludes

An unprecedented research project into how to transform primary care practices into patient-centered medical homes has concluded with the release of a new eight-paper supplement to the May/June issue of Annals of Family Medicine.

8 Jun 2010

Health-care cost for patients after stroke soars to more than $2.5 billion a year in Canada: Study

Health-care costs for patients in just the first six months after they have a stroke is more than $2.5 billion a year in Canada, according to a study presented today at the Canadian Stroke Congress.

8 Jun 2010

Boosting levels of ABCG1 protein in diabetics will improve insulin production

If you think of diabetes onset like an elaborate molecular drama, then a research team led by a La Jolla Institute scientist has unmasked a previously unknown cellular player, which is critical to proper insulin secretion. "Defective insulin secretion is a hallmark of both type 1 and type 2 diabetes," said Catherine Hedrick, Ph.D., a scientist at the La Jolla Institute for Allergy & Immunology, who led the team, which included researchers from the University of Virginia.

8 Jun 2010

Analyst briefing on Asia Pacific Contactless Biometrics Market

Frost & Sullivan's Electronics & Security Practice in Asia Pacific will host an analyst briefing via webinar on the Asia Pacific Contactless Biometrics Market on June 25, 2010 at 11:00 hrs (GMT+08:00hrs) Singapore time.

8 Jun 2010

Vitiligo associated with genes variations linked to body's immune response

Scientists including researchers from the University of Florida have discovered additional evidence that generalized vitiligo - a disease that typically causes patches of white skin on the face, neck and extremities that pop star Michael Jackson may have experienced - is associated with slight variations in genes that play a role in the body's natural defenses.

8 Jun 2010

Research shows silent strokes in young adults are associated with recurrent stroke

Being young doesn't mean you are immune to a stroke. You may feel healthy; you may be 18 or a vigorous 50. And yet you could be more vulnerable than you know. That could be because of the role played by silent risk factors in stroke.

8 Jun 2010

Agilent Technologies selected as primary provider of gas-phase testing instruments for 2010 World Cup

Agilent Technologies Inc. today announced it has been selected by the South African Doping Control Laboratory as the primary provider of gas-phase testing instruments for the 2010 World Cup. The South African Doping Control Laboratory is certified by the World Anti-Doping Agency and will be responsible for all doping testing during the competition.

8 Jun 2010

Medicare bidding program will lead to 'suicide bidding', says Pennsylvania Association of Medical Suppliers

Providers of home medical equipment and services across Pennsylvania are proposing a fiscally responsible alternative to the mislabeled "competitive" bidding scheme currently under way in Medicare that will actually discourage competition, reduce access to care for many of Pennsylvania's more than two million Medicare beneficiaries, and put hundreds of Pennsylvania's homecare providers out of business.

8 Jun 2010

MicroStockProfit.com: ARIA reports net loss of $23.4M for three months ended March 31, 2010

MicroStockProfit.com announces an investment report featuring ARIAD Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

8 Jun 2010

Combined cardiac bypass and liver tumor surgery performed on 63-year-old Nigerian

Adding another feat to the history of cardiothoracic surgery at Fortis Hospitals Bangalore, the team of experts led by noted Dr. Vivek Jawali, Chief Cardiothoracic Surgeon and Dr. Ramcharan Thiagarajan, Consultant Surgical GI & Hepato-Pancreatic Biliary Surgoen has performed a combined cardiac bypass and liver tumor surgery on a 63 year old Nigerian.

8 Jun 2010

Pelosi issues statement in response to HHS Health Insurance Premium Review Grants

Speaker Nancy Pelosi today issued the following statement in response to Health and Human Services Secretary Kathleen Sebelius announcing the availability of $51 million in Health Insurance Premium Review Grants through the Affordable Care Act.

8 Jun 2010

TSO3 to resubmit 510(k) for US regulatory clearance of STERIZONE 125L+ Sterilizer

TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings using ozone, today announced that it has received instructions from US regulatory authorities to resubmit a 510(k) for its STERIZONE(R) 125L+ Sterilizer. As instructed by the Agency, TSO3 intends to provide additional data and to better establish the link between the sterilizer and a variety of accessory products used in the sterilizer, which are also subject to 510(k) clearance and have been previously submitted.

8 Jun 2010

Medical News

FDA grants Cepheid marketing clearance for Xpert SA Nasal Complete molecular test

Patient Home Monitoring to trade under ticker symbol "PHM" on TSX Venture Exchange

New technique to prevent tumours developing in connection with stem cell transplantations

Salix submits efficacy supplement for XIFAXAN NDA for Non-C IBS and IBS-related bloating

UC-MSCT improves symptoms, biochemical values in patients with severe refractory SLE: Study

Columbia completes enrollment in PROCHIEVE 8% Phase III study to reduce preterm birth in short cervix women

USPTO grants ISCO patent to International Stem Cell's hpSC

Value-based wellness programs for patients with metabolic syndrome

Research project to transform primary care practices into patient-centered medical homes concludes

Health-care cost for patients after stroke soars to more than $2.5 billion a year in Canada: Study

Boosting levels of ABCG1 protein in diabetics will improve insulin production

Analyst briefing on Asia Pacific Contactless Biometrics Market

Vitiligo associated with genes variations linked to body's immune response

Research shows silent strokes in young adults are associated with recurrent stroke

Agilent Technologies selected as primary provider of gas-phase testing instruments for 2010 World Cup

Medicare bidding program will lead to 'suicide bidding', says Pennsylvania Association of Medical Suppliers

MicroStockProfit.com: ARIA reports net loss of $23.4M for three months ended March 31, 2010

Combined cardiac bypass and liver tumor surgery performed on 63-year-old Nigerian

Pelosi issues statement in response to HHS Health Insurance Premium Review Grants

TSO3 to resubmit 510(k) for US regulatory clearance of STERIZONE 125L+ Sterilizer

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News